Bank of America’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bank of America’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,450	Closed	-$88K	–	8180
2014 Q4	$88K	Sell	1,450 -1,000	-41%	-$50.2K	﹤0.01%	5981
2014 Q3	$104K	Sell	2,450 -4,630	-65%	-$249K	﹤0.01%	5982
2014 Q2	$437K	Buy	7,080 +3,920	+124%	+$228K	﹤0.01%	4759
2014 Q1	$206K	Buy	3,160 +2,090	+195%	+$141K	﹤0.01%	5417
2013 Q4	$60K	Sell	1,070 -12,120	-92%	-$681K	﹤0.01%	6459
2013 Q3	$809K	Sell	13,190 -2,850	-18%	-$193K	﹤0.01%	4159
2013 Q2	$938K	Buy	+16,040	New	+$987K	﹤0.01%	4122

Other funds holding OREX

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of America's OREX Position: Q2 2018 in Review

Bank of America sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 8,944 shares — an estimated $2K sold.

Bank of America first reported a position in OREX in Q2 2013 and held it in 19 quarters. The position peaked at $21.7M in Q1 2014. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

Bank of America reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Bank of America sold 8,944 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $2K.
Bank of America first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
Bank of America's Orexigen Therapeutics, Inc. position peaked at $21.7M in Q1 2014.
4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.